Protective effect of Bacillus Calmette Guerin (BCG) against leprosy: A population-based case-control study in Nagpur, India

Leprosy Review

Volumn 70, Issue 3, 1999, Pages 287-294

  Zodpey, Sanjay P ^a,d   Bansod, B S ^d   Shrikhande, S N ^a   Maldhure, B R ^b   Kulkarni, S W ^c  

^a GOVERNMENT MEDICAL COLLEGE   (India)

^b Panjab Rao Deshmukh Medical College   (India)

^c DATTA MEGHE INSTITUTE OF MEDICAL SCIENCES   (India)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE;

ADOLESCENT; ADULT; ARTICLE; BCG VACCINATION; CASE CONTROL STUDY; CHILD; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HUMAN; INFANT; LEPROSY; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; SOCIAL STATUS; URBAN AREA;

EID: 0033376057     PISSN: 03057518     EISSN: None     Source Type: Journal    
DOI: 10.5935/0305-7518.19990032     Document Type: Article

References (27)

1. Chaudhury S, Hazra SK, Saha B, Mazumder B, Biswas PC, Chattopadhya D, Saha K. A eight year field trial on antileprosy vaccines among high risk household contacts in the Calcutta Metropolis. Int J Lepr, 1993; 62: 389-394.
2. Convit J, Smith PG, Zuniga M, Sampson C, Ulrich M, Plata JA, Silva J, Molina J, Salgado A. A immunoprophylactic trial with combined Mycobacterium leprae/BCG vaccine against leprosy: preliminary results. Lancet, 1992; 339: 446-450.
3. Lwin K, Sundaresan T, Gyi MM, Bechelli LM, Tamondong C, Garbajosa PG, Sansarricq H, Noordeen SK. BCG vaccination of children against leprosy: fourteen year findings of the trial in Barma. Bull WHO, 1985; 63: 1069-1078.
4. Ponnighaus JM, Fine PEM, Sterne JAC, Wilson RS, Msosa E, Gruer PJK, Jenkins PA, Lucas SB, Liomba G, Bliss L. Efficacy of BCG against leprosy and tuberculosis in northern Malawi. Lancet, 1992; 339: 636-639.
5. Scott GC, Russell DA, Boughton CR, Vincin DR. Untreated leprosy. Probability of shifts in Ridley-Jopling classification. Development of 'flares' or disappearance of clinically apparent disease. Int J Lepr, 1978; 44: 110-122.
6. Stanley SJ, Howland C, Stone MM, Sutherland I. BCG vaccination of children against leprosy in Uganda. Final results. J Hyg Camb, 1981; 87: 233-248.
7. Tripathy SP. The case for BCG. Ann Natl Acad Med Sci (India), 1983; 19: 12-21.
8. Abel L, Cua VV, Oberti J, Lap VD, Due IK, Grossi J, Lagrange PH. Leprosy and BCG in Southern Vietnam (letter). Lancet, 1990; 335: 1536.
9. Baker DM, Nguyen Van Tam JS, Smith SJ. Protective efficacy of BCG vaccine against leprosy in Southern Malawi. Epidemiol Infect, 1993; 111: 21-25.
10. Boelens JJ, Kroes R, Beers SV, Lever P. Protective effect of BCG against leprosy in South Sulawesi, Indonesia. Int J Lepr, 1995; 63: 456-457.
11. Convit J, Smith PG, Zuniga M, Sampson C, Ulrich M, Plata JA, Silva J, Molina J, Salgado A. BCG vaccination protects against leprosy in Venezuela: a case-control study. Int J Lepr, 1993; 61: 185-191.
12. Fine PEM, Ponnighaus JM, Maine N, Clarkson JA, Bliss L. The protective efficacy of BCG against leprosy in northern Malawi. Lancet, 1986; ii: 499-502.
13. Muliyil J, Nelson KE, Diamond EL. Effect BCG on the risk of leprosy in an endemic area: a case-control study. Int J Lepr, 1991; 59: 229-236.
14. Orege PA, Fine PEM, Lucas SB, Obura M, Okela C, Okuku P. Case-control study of BCG vaccination as a risk factor for leprosy and tuberculosis in Western Kenya. Int J Lepr, 1993; 61: 542-549.
15. Rodrigues MLO, Silva SA, Neto JCA, De Andrade Alss, Martelli CMT, Zicker F. Protective effect of intradermal BCG against leprosy: a case-control study in Central Brazil. Int J Lepr, 1992; 60: 335-339.
16. Thuc NV, Abel L, Lap VD, Oberti J, Lagrange PH. Protective effect of BCG against leprosy and its subtypes: a case-control study in Southern Vietnam. Int J Lepr, 1994; 62: 532-538.
17. Suri AK. National Programme for control of tuberculosis. National Institute of Health and Family Welfare, New Delhi, 1988; pp 11-34.
18. WHO. A guide to eliminating leprosy as a public health problem. Geneva: WHO/LEP/95.1, 1995; pp 15-26.
19. Mahajan BK, Gupta MC. Social environment. In: Textbook of preventive and social medicine. New Delhi: Jaypee Bros, 1991; pp 82-86.
20. Smith PG. Retrospective assessment of the effectiveness of BCG vaccination against tuberculosis using the case-control method. Tubercle, 1982; 62: 23-35.
21. Greenberg RS, Ibrahim MA. The case-control study. In: Holland WW, Detels R, Knox G, eds. Oxford textbook of public health. London: Oxford University Press, 1985; pp 123-143.
22. Schlesselman JJ. Case-control studies: design, conduct, analysis. New York: Oxford University Press, 1982; pp 171-226.
23. Miettinen OS. Proportion of disease caused or prevented by a given exposure trait or intervention. Am J Epidemiol, 1974; 99: 325-332.
24. Fernandez JM. The early reaction induced by lepromin. Int J Lepr, 1940; 8: 1-14.
25. Convit J, Rassi E. Lepromin and tuberculin tests in Venezuelan leprosy foci: induction of lepromin reaction by BCG vaccination. Int J Lepr, 1954; 22: 303-310.
26. Fine PEM. BCG vaccination against tuberculosis and leprosy. Br Med Bull, 1988; 44: 691-703.
27. Fine PEM, Ponnighaus JM, Maine N. The distribution and implications of BCG scars in northern Malawi. Bull WHO, 1989; 67: 35-42.